Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 14, 2023

SELL
$100.78 - $112.29 $403 - $449
-4 Reduced 0.19%
2,079 $226,000
Q1 2023

Apr 14, 2023

SELL
$96.86 - $114.01 $66,542 - $78,324
-687 Reduced 24.8%
2,083 $210,000
Q3 2022

Oct 20, 2022

SELL
$96.76 - $112.03 $12,288 - $14,227
-127 Reduced 4.38%
2,770 $268,000
Q2 2022

Jul 12, 2022

BUY
$102.07 - $123.37 $295,696 - $357,402
2,897 New
2,897 $315,000
Q1 2022

Apr 11, 2022

SELL
$114.02 - $139.04 $676,936 - $825,480
-5,937 Closed
0 $0
Q4 2021

Jan 24, 2022

SELL
$115.53 - $141.46 $11,553 - $14,146
-100 Reduced 1.66%
5,937 $836,000
Q3 2021

Oct 12, 2021

SELL
$116.66 - $129.06 $134,159 - $148,419
-1,150 Reduced 16.0%
6,037 $713,000
Q2 2021

Jul 19, 2021

SELL
$105.79 - $124.53 $67,176 - $79,076
-635 Reduced 8.12%
7,187 $833,000
Q1 2021

Apr 23, 2021

SELL
$108.84 - $128.23 $29,931 - $35,263
-275 Reduced 3.4%
7,822 $938,000
Q4 2020

Jan 15, 2021

SELL
$105.0 - $114.42 $27,615 - $30,092
-263 Reduced 3.15%
8,097 $887,000
Q3 2020

Oct 15, 2020

SELL
$91.64 - $111.29 $916 - $1,112
-10 Reduced 0.12%
8,360 $910,000
Q2 2020

Jul 09, 2020

SELL
$76.57 - $98.0 $9,571 - $12,250
-125 Reduced 1.47%
8,370 $765,000
Q1 2020

Apr 16, 2020

SELL
$62.82 - $91.86 $23,620 - $34,539
-376 Reduced 4.24%
8,495 $671,000
Q4 2019

Jan 17, 2020

SELL
$78.51 - $87.4 $146,499 - $163,088
-1,866 Reduced 17.38%
8,871 $771,000
Q3 2019

Oct 09, 2019

SELL
$81.84 - $88.74 $53,932 - $58,479
-659 Reduced 5.78%
10,737 $898,000
Q2 2019

Jul 23, 2019

BUY
$72.88 - $85.0 $830,540 - $968,660
11,396 New
11,396 $959,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $206B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Arden Trust CO Portfolio

Follow Arden Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arden Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Arden Trust CO with notifications on news.